Related Experiment Video
Updated: Dec 20, 2025

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
Parathyroid carcinoma coexisting with multiple parathyroid adenomas: a case report
Masao Takenobu1, Sueyoshi Moritani1, Katsuyuki Kawamoto1
1Kusatsu General Hosipital, Otolaryngology Head and Neck Thyroid Surgery, Shiga 525-8585, Japan.
A rare case of primary hyperparathyroidism caused by parathyroid carcinoma coexisting with multiple parathyroid adenomas is presented. This highlights the diagnostic challenges and the need for careful follow-up in such rare endocrine neoplasia cases.
Area of Science:
- Endocrinology
- Oncology
- Surgical Pathology
Background:
- Primary hyperparathyroidism is typically caused by parathyroid adenoma.
- Parathyroid carcinoma is an infrequent cause of primary hyperparathyroidism.
Observation:
- A 74-year-old female presented with primary hyperparathyroidism and a suspected thyroid tumor.
- Neck imaging revealed multiple parathyroid lesions, with one heterogeneous mass suspicious for malignancy.
- Preoperative diagnosis was multiple parathyroid adenoma and suspected incidental thyroid carcinoma.
Findings:
- Histopathological diagnosis confirmed parathyroid carcinoma coexisting with multiple parathyroid adenomas.
- The patient showed no recurrence one year post-surgery.
- Preoperative diagnosis of parathyroid carcinoma proved challenging.
Implications:
- This case underscores the rarity of parathyroid carcinoma coexisting with parathyroid adenomas.
- Careful follow-up is crucial due to potential associations with Multiple Endocrine Neoplasia type 1 (MEN1).
- Diagnostic difficulties highlight the need for advanced imaging and pathological evaluation.
More Related Videos
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023